Information  X 
Enter a valid email address

Micro Focus Int plc (MCRO)

  Print      Mail a friend

Monday 01 June, 2020

Micro Focus Int plc

Total Voting Rights

RNS Number : 5417O
Micro Focus International plc
01 June 2020
 

1 June 2020

 

 

Micro Focus International plc

 

 

Total Voting Rights

 

In fulfilment of its obligations under DTR 5.6.1 R, Micro Focus International plc (the "Company") notifies the market that, on 31 May 2020, the share capital of the Company consisted of 334,649,413 ordinary shares of 10 pence each and a further 29,816,770 ordinary shares held in Treasury.

 

Therefore, the total number of voting rights in the Company is 334,649,413.  This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

Micro Focus  Tel: +44 (0)1635 32646

Stephen Murdoch, CEO                                       [email protected]

Brian McArthur-Muscroft, CFO

Ben Donnelly, Investor relations

 

 

Brunswick  Tel: +44 (0) 20 7404 5959

Sarah West    [email protected]

Jonathan Glass 

 

 

 

Notes to Editors:

About Micro Focus

Micro Focus (LSE: MCRO.L, NYSE: MFGP) is a global enterprise software company supporting the technology needs and challenges of the Global 2000.  Our solutions help organizations leverage existing IT investments, enterprise applications and emerging technologies to address complex, rapidly evolving business requirements while protecting corporate information at all times. Our product portfolios are Security, IT Operations Management, Application Delivery Management, Information Management & Governance and Application Modernization & Connectivity. For more information, visit: www.microfocus.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVRUPURPQUPUGUG

a d v e r t i s e m e n t